People: Alkermes Plc (ALKS.O)

ALKS.O on Nasdaq

46.73USD
19 Sep 2014
Price Change (% chg)

$0.63 (+1.37%)
Prev Close
$46.10
Open
$46.40
Day's High
$46.86
Day's Low
$46.21
Volume
1,374,997
Avg. Vol
743,753
52-wk High
$54.25
52-wk Low
$29.36

Search Stocks

Dixon, Wendy 

Brief Biography

Dr. Wendy L. Dixon is an Independent Director of Alkermes Plc. From January 2011 to September 16, 2011, Dr. Dixon served on Alkermes' board of directors. She has experience in the pharmaceutical and biotechnology industries, combining a technical background with experience in drug development, regulatory affairs and marketing. She directed the launches and growth of more than 20 pharmaceutical products. From 2001 to 2009 she was Chief Marketing Officer and President, Global Marketing for Bristol-Myers Squibb where she served on the Executive Committee. From 1996 to 2001 she was Senior Vice President, Marketing at Merck and prior to that she held executive management positions at West Pharmaceuticals, Osteotech, and Centocor and various positions at SmithKline and French (now GlaxoSmithKline) in marketing, regulatory affairs, project management and as a biochemist. Dr. Dixon is on the board of directors of Furiex Pharmaceuticals, Orexigen Therapeutics, Ardea Biosciences and Incyte Corporation, all publicly traded biotechnology or pharmaceutical companies, and was formerly on the board of Dentsply International. She is a Senior Advisor to The Monitor Group, a worldwide consulting firm.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Richard Pops

6,587,780

Shane Cooke

3,164,580

James Frates

1,831,190

Gordon Pugh

1,965,720

Kathryn Biberstein

2,113,310

Rebecca Peterson

--
As Of 30 Mar 2013
Search Stocks